Previous close | 9.00 |
Open | 9.40 |
Bid | 7.20 |
Ask | 10.50 |
Strike | 22.50 |
Expiry date | 2024-06-21 |
Day's range | 9.00 - 9.40 |
Contract range | N/A |
Volume | |
Open interest | 5.75k |
It is doubtless a positive to see that the Guardant Health, Inc. ( NASDAQ:GH ) share price has gained some 58% in the...
PALO ALTO, Calif., June 04, 2024--Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced the launch of a new version of its Guardant360 TissueNext test that expands the number of genes it identifies in a tumor tissue sample to 498. These genes, or cancer biomarkers, enable oncologists to identify the targeted therapies or treatment strategies that are most effective for patients with advanced cancer. In addition to the panel expansion, Guardant has improved the
PALO ALTO, Calif., June 03, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced its research collaborators from Washington University’s Siteman Cancer Center will lead an oral presentation today at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting highlighting the potential role of liquid biopsy in addressing racial inequities in enrollment in clinical trials and in the use of targeted therapies for advanced breast cancer.